Search

Your search keyword '"Anna, Antonell"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Anna, Antonell" Remove constraint Author: "Anna, Antonell"
126 results on '"Anna, Antonell"'

Search Results

1. Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology

2. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

3. Early‐onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late‐onset

4. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

5. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

6. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

7. APP‐derived peptides reflect neurodegeneration in frontotemporal dementia

8. Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia

9. Disease-related cortical thinning in presymptomatic granulin mutation carriers

10. Microglial Hyperreactivity Evolved to Immunosuppression in the Hippocampus of a Mouse Model of Accelerated Aging and Alzheimer’s Disease Traits

11. Differential early subcortical involvement in genetic FTD within the GENFI cohort

12. Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

13. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease

14. The <scp> APOE4 </scp> effect: structural brain differences in Alzheimer's disease according to the age at symptom onset

15. Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer’s Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines

16. Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment

17. A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

18. New insights into the genetic etiology of Alzheimer's disease and related dementias

19. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

20. Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer’s disease

21. Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease

22. Sex differences in early-onset Alzheimer's disease

23. Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort

24. Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

25. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias

26. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

27. A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers

28. Impact of COVID‐19 pandemic in an early‐onset dementia clinic in Barcelona

29. Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease

30. Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

31. Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants

32. Disease-related cortical thinning in presymptomatic granulin mutation carriers

33. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

34. Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy

35. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

36. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort

37. Differential gene expression in genetic and early‐onset Alzheimer’s disease in two biological samples: Brain tissue and lymphoblastoid cell lines

38. Distinct neuropsychological presentation and progression between early‐ and late‐onset Alzheimer’s disease

39. Functional network alterations in early‐onset Alzheimer’s disease studied with resting‐state fMRI

40. An ABCA7 partial deletion and a GRN variant in a semantic variant of primary progressive aphasia patient

41. Four years’ experience in an early‐onset dementia clinic in Barcelona

42. Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment

43. Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

44. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease

45. The hippocampal longitudinal axis—relevance for underlying tau and TDP-43 pathology

46. Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation

47. P3-370: GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN LONGITUDINAL BRAIN CHANGES AND BASELINE LEVELS OF CSF ALZHEIMER'S DISEASE AND GLIAL BIOMARKERS IN HEALTHY ELDERS

48. Frontotemporal Dementia Caused by the P301L Mutation in the MAPT Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain

49. Common variants in Alzheimers disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores

50. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

Catalog

Books, media, physical & digital resources